Fennec Pharmaceuticals (FENC) Equity Ratio (2016 - 2025)
Fennec Pharmaceuticals (FENC) has disclosed Equity Ratio for 15 consecutive years, with 0.09 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Equity Ratio fell 3.9% year-over-year to 0.09, compared with a TTM value of 0.09 through Sep 2025, down 3.9%, and an annual FY2024 reading of 0.13, up 69.8% over the prior year.
- Equity Ratio was 0.09 for Q3 2025 at Fennec Pharmaceuticals, up from 0.17 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.9 in Q1 2021 and bottomed at 0.53 in Q3 2023.
- Average Equity Ratio over 5 years is 0.07, with a median of 0.09 recorded in 2024.
- The sharpest move saw Equity Ratio soared 112.95% in 2024, then crashed 674.05% in 2025.
- Year by year, Equity Ratio stood at 0.73 in 2021, then plummeted by 113.05% to 0.1 in 2022, then tumbled by 353.66% to 0.43 in 2023, then surged by 69.8% to 0.13 in 2024, then surged by 30.2% to 0.09 in 2025.
- Business Quant data shows Equity Ratio for FENC at 0.09 in Q3 2025, 0.17 in Q2 2025, and 0.13 in Q1 2025.